Teva Pharmaceutical Industries Limited (TEVA) shares surged 24.91 percent to $21.75 on Wednesday after the company reported a return to profitability for the third quarter.
The pharmaceutical company reported a net profit of $433 million, or $0.37 per share, as opposed to a net loss of $437 million, or $0.39 per share, during the same time last year. Net revenue increased 1 percent in local currency terms and 3 percent to $4.48 billion from $4.33 billion the previous year.
Throughout the session, the stock fluctuated between $22.71 and $24.90 on the New York Stock Exchange, having opened at $23.06. In contrast to its previous close of $20.46, it was last seen at $24.67. About 31.8 million shares were traded, more than three times the typical 10 million.
Over the previous 52 weeks, Teva's stock has fluctuated between $12.47 and $24.90.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.